Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.47787 | 19 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.45499 | 19 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.44912 | 19 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.41561 | 19 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.39854 | 18 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.50468 | 18 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.46932 | 18 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.43781 | 19 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.43222 | 19 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.4526 | 19 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.44131 | 19 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.43123 | 19 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.44919 | 19 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.44552 | 19 |